Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
2019-11-28 10:37

New presentation from Stora Aktiedagen Stockholm on 25 Nov

CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Stockholm on 25 November. Would you like to read more about the programme and how to sign up, see attached notification.

 

2023-01-23 10:00
Qlife reaches important milestone: launches Egoo Health and CRP test
2023-01-11 09:00
Qlife completes freeze-drying project necessary for home-use
2022-11-29 16:54
Correction: Qlife Holding AB, Interim report Q3 2022
2022-11-18 10:51
Qlife puts development of two-in-one test on hold
2022-11-02 18:00
Qlife announces the last day for trading in BTU and the first day for trading in warrants series TO 2022
2022-10-21 14:00
Nomination Committee appointed for Qlife Holding's Annual General Meeting 2023
2022-10-20 19:00
Qlife announces outcome in rights issue
2022-10-12 08:00
Qlife takes Egoo Health to Biohacker Summit 2022 – to engage with potential consumers and gain industry insights
2022-09-30 18:01
Qlife publishes prospectus due to upcoming rights issue

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health
Last published: 2022-08-15

Links

  • About
  • Investors
  • Egoo.health

Qlife is born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on health-care into tomorrow's focus on health-empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. it's how we contribute to improving quality of life for every individual and for the greater society.